Considering that CD44 mediates HSPC binding to the extracellular matrix and thereby regulates haematopoiesis, we hypothesise that downregulation of CD44 on HSCs contributes to impaired haematopoietic differentiation and cytopenia in MDS [41, 42]. This evidence concerns the gene CD44 and myelodysplastic syndrome.